Herrscher H - Search Results

1

[MiT family translocation renal cell carcinomas: Natural history, molecular features and multidisciplinary management].

Herrscher H, Boilève A, Lindner V, Barthélémy P, Hutt É, Pierard L, Kurtz JE, Rioux-Leclercq N, Lang H, Malouf GG. Herrscher H, et al. Bull Cancer. 2020 Feb;107(2):272-280. doi: 10.1016/j.bulcan.2019.11.010. Epub 2020 Feb 7. Bull Cancer. 2020. PMID: 32044098 Review. French.

2

Intensive care for patients with gastric cancers: outcome and survival prognostic factors.

Herrscher H, Artzner T, Severac F, Faitot F, Kurtz JE, Janssen-Langenstein R, Maestraggi Q, Schneider F, Michard B. Herrscher H, et al. J Gastrointest Oncol. 2019 Apr;10(2):292-299. doi: 10.21037/jgo.2018.10.11. J Gastrointest Oncol. 2019. PMID: 31032097 Free PMC article.

3

[Immune checkpoint inhibitors for treatment of advanced stage melanoma].

Lupu J, Herrscher H, Robert C. Lupu J, et al. Among authors: herrscher h. Rev Prat. 2020 May;70(5):471-474. Rev Prat. 2020. PMID: 33058629 French.

4

Cerebral lymphoma presenting as a rhombencephalitis: Case report and review of the literature.

Herrscher H, Artzner T, Coca HA, Schneider F, Proust F, Guillot M. Herrscher H, et al. Rev Neurol (Paris). 2019 Jun;175(6):412-414. doi: 10.1016/j.neurol.2018.12.005. Epub 2019 Apr 25. Rev Neurol (Paris). 2019. PMID: 31030899 Review. No abstract available.

5

A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey.

Cherkaoui Z, González C, Wakabayashi T, Delattre B, Léost E, Serra S, Huppertz J, Klein F, Stéphan M, Meyer JM, Schaff A, Martinis E, Bangoura E, Kieffer S, Blanès S, Haddad E, De Guio G, Felli E, Pernot S, Marescaux J, Mutter D, Lugiez C, Pessaux P; IHU-VBHC Working Group. Cherkaoui Z, et al. Ann Surg Oncol. 2021 Feb;28(2):1069-1078. doi: 10.1245/s10434-020-08679-0. Epub 2020 Jun 8. Ann Surg Oncol. 2021. PMID: 32514806

6

Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting.

Herrscher H, Robert C. Herrscher H, et al. Curr Opin Oncol. 2020 Mar;32(2):106-113. doi: 10.1097/CCO.0000000000000610. Curr Opin Oncol. 2020. PMID: 31876547 Review.

7

Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm.

Robert C, Marabelle A, Herrscher H, Caramella C, Rouby P, Fizazi K, Besse B. Robert C, et al. Among authors: herrscher h. Nat Rev Clin Oncol. 2020 Nov;17(11):707-715. doi: 10.1038/s41571-020-0399-6. Epub 2020 Jul 7. Nat Rev Clin Oncol. 2020. PMID: 32636502 Review.

8

Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019.

Herrscher H, Sauer B, Truntzer P, Robert C. Herrscher H, et al. Eur J Cancer. 2021 May;149:91-93. doi: 10.1016/j.ejca.2021.03.003. Epub 2021 Mar 14. Eur J Cancer. 2021. PMID: 33839589 Free PMC article. No abstract available.

9

Generalised morphea induced by pembrolizumab.

Herrscher H, Tomasic G, Castro Gordon A. Herrscher H, et al. Eur J Cancer. 2019 Jul;116:178-181. doi: 10.1016/j.ejca.2019.05.018. Epub 2019 Jun 12. Eur J Cancer. 2019. PMID: 31202088 No abstract available.

10

[Cutaneous lesions and polyarthritis].

Guillochon-Petitcuenot C, Herrscher H, Sachs C, De Briel D, Schutte M, Spielmann L, Moreau P, Messer L. Guillochon-Petitcuenot C, et al. Among authors: herrscher h. Rev Med Interne. 2017 Dec;38(12):853-855. doi: 10.1016/j.revmed.2017.03.010. Epub 2017 Apr 10. Rev Med Interne. 2017. PMID: 28408063 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters